These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7511189)

  • 1. Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment.
    Preisler HD; Gopal V
    Leuk Res; 1994 Mar; 18(3):149-60; discussion 161. PubMed ID: 7511189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia.
    Preisler HD; Raza A; Baccarani M
    Leuk Lymphoma; 1993; 11 Suppl 1():303-6. PubMed ID: 7504547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and Prospects in Pediatric Leukemia.
    Madhusoodhan PP; Carroll WL; Bhatla T
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):229-241. PubMed ID: 27283082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
    Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
    Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
    Savchenko VG; Isaev VG; Abakumov EM; Khoroshko ND; Turkina AG; Sokolov AN; Viadro MM; Navashin SM
    Antibiot Khimioter; 1992 Jul; 37(7):47-9. PubMed ID: 1456812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ATRA (all-trans retinoic acid) in chronic myeloid leukemia?].
    Rák K
    Orv Hetil; 2002 Jun; 143(23):1449-50; author reply 1450. PubMed ID: 12132331
    [No Abstract]   [Full Text] [Related]  

  • 7. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
    Williams RT; Sherr CJ
    Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of retinoic acid on the cytogenetic remission in the first chronic phase of chronic myeloid leukemia treated with interferon].
    Egyed M; Mihályfalvi Z; Kollár B; Rumi G; Keller E; Vass J; Fekete S
    Orv Hetil; 2001 Nov; 142(44):2421-5. PubMed ID: 11766235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of some studies of chronic myelogenous leukemia: biological-clinical observations and viewing the disease as a chaotic system.
    Preisler H; Raza A
    Leuk Lymphoma; 1993; 11 Suppl 1():145-50. PubMed ID: 8251888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vindesine in the treatment of leukaemia.
    Gökbuget N; Hoelzer D
    Leuk Lymphoma; 1997 Aug; 26(5-6):497-506. PubMed ID: 9389357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a review of three consecutive trials of the treatment of poor prognosis patients.
    Preisler H; Raza A; Larson R; Goldberg J; Tricot G; Carey M; Kukla C
    Leuk Res; 1991; 15(9):773-80. PubMed ID: 1921456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hematological malignancies].
    Usui N
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):358-66. PubMed ID: 17353625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The standard treatments for patients with hematological malignancies in Japan].
    Ishizawa K
    Gan To Kagaku Ryoho; 2007 May; 34(5):709-12. PubMed ID: 17496442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide.
    Maia RC; Carriço MK; Klumb CE; Noronha H; Coelho AM; Vasconcelos FC; Ruimanek VM
    J Exp Clin Cancer Res; 1997 Dec; 16(4):419-24. PubMed ID: 9505216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia].
    Nakadate H; Hatayama Y; Hatae Y; Takeda T
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2907-10. PubMed ID: 3178240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
    Román J; Alvarez MA; Torres A
    Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
    Hackanson B; Rückert A; Lübbert M
    Eur J Haematol; 2009 Dec; 83(6):611-2. PubMed ID: 19682063
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukemia.
    McKenna SJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):137-9. PubMed ID: 10673646
    [No Abstract]   [Full Text] [Related]  

  • 19. [New therapeutic approaches in acute myeloblastic leukemia (AML) and chronic myeloid leukemia (CML)].
    Marie JP
    Bull Cancer; 1997 Apr; 84(4):451-2. PubMed ID: 9238175
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current clinical trials using new targeted therapies for myeloid leukemia and the research trends].
    Ishizawa J; Saya H
    Nihon Rinsho; 2009 Oct; 67(10):1932-7. PubMed ID: 19860193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.